Treatment of Hyperammonemia in Liver Failure: A Tale of Two Enzymes

Gastroenterology

Volumn 136, Issue 7, 2009, Pages 2048-2051

  Jalan, Rajiv ^a   Lee, William M ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; GLUTAMATE AMMONIA LIGASE; GLUTAMINASE; ORNITHINE ASPARTATE; PHENYLACETIC ACID; PLACEBO;

AMMONIA BLOOD LEVEL; BRAIN EDEMA; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; EDITORIAL; ENZYME ACTIVITY; HUMAN; HYPERAMMONEMIA; INTRACRANIAL PRESSURE MONITORING; LIVER CIRRHOSIS; LIVER FAILURE; METABOLISM; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL;

EID: 66149086491     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.04.016     Document Type: Editorial

References (23)

1. O'Grady J., Alexander G., Hayllar K., et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97 (1989) 439-445
2. Jalan R. Intracranial hypertension in acute liver failure: pathophysiological basis of rational management. Semin Liver Dis 23 (2003) 271-282
3. Martinez-Hernandez A., Bell K.P., and Norenberg M.D. Glutamine synthetase: glial localization in brain. Science 195 (1977) 1356-1358
4. Clemmesen J.O., Larsen F.S., Kondrup J., et al. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29 (1999) 648-653
5. Bhatia V., Singh R., and Acharya S.K. Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut 55 (2006) 98-104
6. Jalan R., Olde Damink S.W., Hayes P.C., et al. Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia, cerebral blood flow. J Hepatol 41 (2004) 613-620
7. Bernal W., Hall C., Karvellas C.J., et al. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 46 (2007) 1844-1852
8. Häussinger D., Kircheis G., Fischer R., et al. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?. J Hepatol 32 (2000) 1035-1038
9. Wright G., Davies N.A., Shawcross, et al. Endotoxemia produces coma and brain swelling in bile duct ligated rats. Hepatology 45 (2007) 1517-1526
10. Pedersen H.R., Ring-Larsen H., Olsen N.V., et al. Hyperammonemia acts synergistically with lipopolysaccharide in inducing changes in cerebral hemodynamics in rats anaesthetised with pentobarbital. J Hepatol 47 (2007) 245-252
11. Acharya S.K., Bhatia V., Sreenivas V., et al. Efficacy of l-ornithine l-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology 136 (2009) 2159-2168
12. Olde Damink S.W., Jalan R., Redhead D.N., et al. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology 36 (2002) 1163-1171
13. Romero-Gómez M., Ramos-Guerrero R., Grande L., et al. Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy. J Hepatol 41 (2004) 49-54
14. Rose C., Michalak A., Rao K.V., et al. L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain oedema in rats with acute liver failure. Hepatology 30 (1999) 636-640
15. Shawcross D.L., Davies N.A., Williams R., et al. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 40 (2004) 247-254
16. Lee W.M. Acute liver failure in the United States. Semin in Liver Dis 23 (2003) 217-226
17. Polson J., and Lee W.M. AASLD position paper: the management of acute liver failure. American Association for the Study of Liver Disease. Hepatology 41 (2005) 1179-1197
18. Vaquero J., Fontana R.J., Larson A.M., et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 11 (2005) 1581-1589
19. Shawcross D., and Jalan R. Dispelling myths in the treatment of hepatic encephalopathy. Lancet 365 (2005) 431-433
20. Jalan R., Wright G., Davies N.A., et al. L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy. Med Hypotheses 69 (2007) 1064-1069
21. Davies N.A., Wright G., Ytrebø L.M., et al. L-ornithine and phenylacetate synergistically produces sustained reduction in ammonia and brain water in cirrhotic rats. Hepatology (2009) in press
22. Ytrebø L.M., Kristiansen R.G., Mæhre H., et al. l-Ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure. Hepatology (2009) in press
23. Lee W.N., Hynan L.S., Rossaro L., et al., ALFSG. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology (2009) in press